Semler Scientific, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 02, 2021 at 09:01 pm
Share
Semler Scientific, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 14.311 million compared to USD 6.373 million a year ago. Operating income was USD 6.464 million compared to USD 960,000 a year ago. Net income was USD 6.688 million compared to USD 1.075 million a year ago. Basic earnings per share from continuing operations was USD 1 compared to USD 0.16 a year ago. Diluted earnings per share from continuing operations was USD 0.83 compared to USD 0.13 a year ago. For the half year, sales was USD 27.494 million compared to USD 15.803 million a year ago. Operating income was USD 12.482 million compared to USD 4.411 million a year ago. Net income was USD 11.565 million compared to USD 3.748 million a year ago. Basic earnings per share from continuing operations was USD 1.72 compared to USD 0.57 a year ago. Diluted earnings per share from continuing operations was USD 1.42 compared to USD 0.47 a year ago.
Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patientâs vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.